Molecular detection of anaplastic lymphoma kinase gene rearrangements in lung and other cancers. Determines candidacy for ALK-targeted therapy and predicts treatment response.
Manufactured by
Guangdong Guangzhou, China
Burning Rock Dx (NASDAQ: BNR) is a global precision oncology leader specializing in NGS-based diagnostics for both tissue and liquid biopsy. With internationally accredited labs (CLIA, CAP, ISO15189, ISO13485) and deep NGS expertise, the company offers a broad portfolio of in-house assays and integrated solutions across the oncology development cycle. Burning Rock supports pharmaceutical development and decentralized clinical implementation, partnering with biopharma and clinical labs to advance trials, biomarker research, and real-world diagnostics. Key milestones include two NMPA-approved IVD kits, four CE-marked assays, and Breakthrough Device Designations from both the FDA and NMPA for its multi-cancer early detection test. Burning Rock is committed to transforming cancer care through innovative, science-driven solutions. In addition to the CLIA / CAP laboratory in the United States, we have a CLIA / CAP / ISO 15189 / ISO13485 lab in Guangzhou, China, which also obtained the technical certification of “High-throughput sequencing laboratory” issued by the Guangdong Center for Clinical Laboratory. We have passed over 200 inter-laboratory quality evaluations organized by NCCL, PQCC, EMQN, CAP, and other authoritative organizations.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
International Company for medical eq.
Egypt · 2 relevant products
Wuhan YZY Medical Science and Technology Co.,Ltd.
China · 3 relevant products
Labcorp
United States · 1 relevant product
GENETRON HEALTH (BEIJING) CO., LTD
China · 2 relevant products
A.Q.MEDICAL TECHNOLOGY CO.,LTD.
China · 1 relevant product
Yaneng BIOscience (Shenzhen) Co.,Ltd.
China · 2 relevant products
Siemens Healthineers Ltd.
China · 1 relevant product
Shanghai Biotecan pharmaceuticals Co.,Ltd
China · 3 relevant products
Life Medical Diagnostics LLC
United Arab Emirates · 1 relevant product
Autobio Diagnostics Co., Ltd.
China · 1 relevant product
47 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →6 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 105 closest product alternatives
International Company for medical eq. · Egypt
Molecular diagnostic testing for cancer detection and monitoring.
International Company for medical eq. · Egypt
Molecular diagnostic testing for tissue compatibility and transplant monitoring.
Wuhan YZY Medical Science and Technology Co.,Ltd. · China
Diagnostic kit for analyzing cancer-related genetic mutations and biomarkers. Provides genomic information to support targeted therapy selection and treatment planning.
Labcorp · United States
Advanced blood-based testing for detection of circulating tumor DNA and other biomarkers. Provides non-invasive alternatives to tissue biopsy for cancer diagnosis and monitoring.
GENETRON HEALTH (BEIJING) CO., LTD · China
Molecular diagnostic test utilizing circulating tumor DNA and biomarkers from blood samples. Enables non-invasive cancer screening and early detection. Supports monitoring of treatment response and recurrence in cancer patients.
A.Q.MEDICAL TECHNOLOGY CO.,LTD. · China
An antibody reagent used in pathology and diagnostic applications to detect anaplastic lymphoma kinase protein expression in tissue samples. It is utilized in immunohistochemical testing for cancer diagnosis and classification.
Yaneng BIOscience (Shenzhen) Co.,Ltd. · China
Molecular testing kit for detecting breast cancer-related genetic alterations, enabling risk stratification and clinical decision-making in oncology care.
Siemens Healthineers Ltd. · China
Genetic and molecular testing for disease identification and characterization. Supports oncology, infectious disease, and hereditary disease diagnosis.
Shanghai Biotecan pharmaceuticals Co.,Ltd · China
Precision medicine test identifying optimal chemotherapy agents for individual tumors based on molecular characteristics. Guides targeted drug selection and improves treatment efficacy.
Life Medical Diagnostics LLC · United Arab Emirates
Advanced molecular diagnostic testing service for genetic and molecular-level analysis of diseases. The service enables precise diagnosis and personalized treatment approaches.
Autobio Diagnostics Co., Ltd. · China
Blood and tissue-based tests for detection of tumor markers indicating cancer presence and type. Used in oncology for cancer screening, diagnosis, and monitoring.
PHC Corporation · Japan
Laboratory testing services specializing in cancer detection and identification through tissue analysis and biomarker assessment. These services support early detection and treatment planning for cancer patients.
93 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products